Verisante Technology, Inc. (VRSEF: OTCQX International) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Verisante Technology, Inc. (VRSEF: OTCQX International) | Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update

Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 2, 2014) - Verisante Technology, Inc . (TSX VENTURE:VRS)(OTCQX:VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has released its financial results for the first quarter ended March 31, 2014.

Highlights of the quarter include

  • Launched new product at SPIE Photonics West Conference in San Francisco, a Raman Spectrometer designed for the research market
  • Hires a Director of Sales and Canadian Sales representative to establish the Company's in-house sales team
  • Expands intellectual property portfolio with the issuance of a Chinese Patent entitled "Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements Obtained During Endoscopy Imaging"

"We are pleased to report continued progress with our renewed sales and marketing efforts for Aura™," said Thomas Braun, President & CEO. "Bringing together our own in house sales team enables us to have flexibility with pricing while controlling margins and also helps us build stronger, direct relationships with our customers. With a 3-6 month expected sales cycle for medical devices, we expect our direct sales strategy to start bringing in positive results by the second half of 2014".

Subsequent to putting together an in-house sales and marketing team in Q1, Verisante has placed two Aura™ devices into clinics in Ontario and has received its first purchase order for the newly launched VRS product, a Raman Spectrometer designed for the research market from a research University in the United States.

Verisante also continues to streamline its production and manufacturing facilities and personnel to preserve cash and focus resources on revenue generating operations to ensure the Company continues with the most cost effective and efficient path of commercialization.

In addition, the Company continues to prepare a submission with the FDA for Aura™ and is pursuing regulatory approvals in Brazil and Mexico.

The Company also recently completed a Core™ commercial prototype for the detection of lung cancer, which will be used to prepare Verisante's application for regulatory approval in Canada, Europe, USA and China for the lung cancer indication.

Revenues

Revenues are from the direct sale of an Aura™ device. The Company normally recognizes revenue when units are shipped, however, as a result of challenges in collecting on some accounts receivables, the Company now recognizes revenue only once the substantial risk of collecting has been minimized. The Company will also require certain customers to pay a deposit or make payment in full on any future orders before devices are shipped. For the quarter ending March 31, 2014 the Company recognized revenue of $40,000 compared to $235,000 reported for the same period in 2013.

The terms of sale of Aura™ devices are particular to the distribution agreements signed with each exclusive Distributor Europe. Distributors have terms of sale which include shipping EXWorks the Company's manufacturing warehouse and payment terms of net 30-90 days. Devices sold directly by the Company have terms of EXWorks the Company's manufacturing warehouse and payment terms of net 30 days.

After the Company terminated its Canadian distribution agreement to pursue direct sales of Aura™ in Canada, it made a strategic decision to not aggressively pursue sales in Canada until such time as a trained and qualified direct sales team was in place. During the quarter ended March 31, 2014, the Company hired a Director of Sales and Canadian Sales Representative and is preparing for a full product launch of Aura™ with this direct sales team.

Expenses

Total expenses for the quarter ended March 31, 2014 was $1,055,694 as compared to $1,214,276 for the same period in 2013, representing a decrease of $158,582 or 13%. The decrease in expenses from 2014 to 2013 is mainly attributed to a substantial decrease stock based compensation and the Company's efforts to lower general and administrative expenses.

Salaries remained fairly consistent over the three months ending March 31, 2014 ($257,793) as compared to the same period in 2013 ($242,626). Professional Fees (which include Investor Relations fees) decreased by $25,467, or 17% over the three months ending March 31, 2014 as compared to the same period in 2013. Audit and accounting fees increased significantly during the three months ending March 31, 2014 as compared to the same period in 2013, attributed mainly to the increasing complexities of accounting for manufacturing and inventory in 2013.

In connection with the Company's consolidation of operations, engineering and manufacturing space, rent decreased by $25,202 in the three month period ending March 31, 2014 over 2013.

The Company's full Q1 Financials and MD&A can be found as filed at www.sedar.com and also on the Company's website at www.verisante.com .

About Veris a nte Technology, Inc.

Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer . The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and tested and refined at the Skin Care Centre at Vancouver General Hospital. This exclusive platform technology allows Verisante to develop and offer a range of compact, non-invasive cancer detection devices that offer physicians immediate results for many of the most common cancers. Aura™ has been approved for sale in Canada, Europe and Australia. Core™ has not yet been approved for sale.

Verisante Aura™ was awarded the 2014 North American Technology Innovation of the Year Award for In Vivo Cancer Detection by Frost & Sullivan , Popular Science Magazin e's " Best of What's New Award " for 2011, awarded a 2013 Prism Award for Innovation in Photonics and an Edison Award for Excellence in Innovation in 2013. Verisante Core™ was named one of the top 10 cancer breakthroughs of 2011 by the Canadian Cancer Society.

The TSX Venture Exchange has neither approved nor disapproved of the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of medical devices, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.

Verisante Technology, Inc.
Thomas Braun, President & CEO
Telephone: (604) 605-0507
Email: info@verisante.com
Website: www.verisante.com
Youtube: www.youtube.com/verisante
Twitter: www.twitter.com/verisante
Facebook: www.facebook.com/verisante

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 258

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 334

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 333

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 282

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 546

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 461

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 466

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 289

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 335

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading

Top 5 Most Recently Viewed Articles

Apple Inc. Announces Record Q4 Results and Product Launches

Updated Category News Views 236

Apple Achieves Remarkable Fourth Quarter Results Apple Inc. has announced its financial performance for the fourth quarter of its fiscal year 2024, showcasing stellar results that reflect the company's growth and expansion in the tech industry. The tech giant reported quarterly revenue hitting a staggering $94.9 billion, which represents a 6% increase compared to the...

Continue Reading
China-Russia Culture Fair Boosts Jiamusi, Heilongjiang

Updated Category News Views 100

Jiamusi: A Cultural Crossroad in Northeast China Imagine this: Jiamusi, nestled in the embrace of Heilongjiang Province, stepping into the spotlight as it co-hosts the 16th China-Russia culture fair. This northeast city isn't just another dot on the map. It's gearing up to be a hub of cultural buzz, packed with ties that go beyond borders. From July through September,...

Continue Reading
Unlocking Sustainability in Broadband Using Existing Networks

Updated Category News Views 176

Unlocking Sustainability in Broadband Using Existing Networks LUND, Sweden — InCoax Networks has introduced a groundbreaking whitepaper addressing the modernization of broadband infrastructure in multi-dwelling units (MDUs). This initiative is not only cost-effective but also significantly improves the environmental impact associated with deploying broadband services....

Continue Reading
Interlink Electronics Secures NASA Grant for Air Quality Solutions

Updated Category News Views 174

Interlink Electronics Receives Significant Funding from NASA Recognizes Company's leading position in gas sensor research and commercialization Interlink Electronics, Inc. (NASDAQ: LINK), a premier provider of innovative sensors and electronic solutions, has received a significant boost with a $150,000 award from NASA. This funding is designated for the development of...

Continue Reading
Burford Capital Set to Reveal 3Q24 Financial Insights Soon

Updated Category News Views 154

Burford Capital Set to Release 3Q24 Financial Results Burford Capital Limited, renowned for its leadership in finance and asset management focused on legal services, has announced the date for its financial results. The firm is poised to share critical insights regarding its performance for the three and nine months ending September 30, 2024. Details of the Financial...

Continue Reading